Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Energy & Commerce To Continue Foraging Through Vytorin Data

Executive Summary

The House Energy & Commerce Committee intends to keep hounding Merck and Schering-Plough for data and internal communications on how the company handled the release of information from three trials on Vytorin (simvastatin/ezetimibe)
Advertisement

Related Content

IRB Problems Will Increase Congressional Pressure On Industry Trial Designs
IRB Problems Will Increase Congressional Pressure On Industry Trial Designs
IRBs To Be Subject Of House Hearing After “Congressional Sting Operation”
Will Vytorin Fallout Include ENHANCEd Reporting Requirements For All Trials?
Will Vytorin Fallout Include ENHANCEd Reporting Requirements For All Trials?

Topics

Advertisement
UsernamePublicRestriction

Register

PS050725

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel